Literature DB >> 16461943

Screening for transglutaminase-catalyzed modifications by peptide mass finger printing using multipoint recalibration on recognized peaks for high mass accuracy.

Cecilia Sundby Emanuelsson1, Sandor Boros, Karin Hjernoe, Wilbert C Boelens, Peter Hojrup.   

Abstract

Detection of posttranslational modifications is expected to be one of the major future experimental challenges for proteomics. We describe herein a mass spectrometric procedure to screen for protein modifications by peptide mass fingerprinting that is based on post-data acquisition improvement of the mass accuracy by exporting the peptide mass values into analytical software for multipoint recalibration on recognized peaks. Subsequently, the calibrated peak mass data set is used in searching for modified peptides, i.e., peptides possessing specific mass deviations. In order to identify the location of Lys- and Gln-residues available for transglutaminase-catalyzed isopeptide bond formation, mammalian small heat shock proteins (sHsps) were screened for labeling with the two hexapeptide probes GQDPVR and GNDPVK in presence of transglutaminase. Peptide modification due to cross-linking of the GQDPVR hexa-peptide probe was detected for C-terminal Lys residues. Novel transglutaminase-susceptible Gln sites were identified in two sHsps (Q31/Q27 in Hsp20 and HspB2, respectively), by cross-linking of the GNDPVK hexapeptide probe. Deamidation of specific Gln residues was also detected, as well an isopeptide derived from intramolecular Gln-Lys isopeptide bond formation. We conclude that peptide mass fingerprinting can be an efficient way of screening for various posttranslational modifications. Basically any instrumentation for MALDI mass spectrometry can be used, provided that post-data acquisition recalibration is applied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16461943      PMCID: PMC2291725     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  37 in total

1.  Hsp26: a temperature-regulated chaperone.

Authors:  M Haslbeck; S Walke; T Stromer; M Ehrnsperger; H E White; S Chen; H R Saibil; J Buchner
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

2.  Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2.

Authors:  Y C Choi; G T Park; T S Kim; I N Sunwoo; P M Steinert; S Y Kim
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 3.  Proteomics to study genes and genomes.

Authors:  A Pandey; M Mann
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

4.  Enhancing the intensities of lysine-terminated tryptic peptide ions in matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  R L Beardsley; J A Karty; J P Reilly
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

Review 5.  Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis.

Authors:  M R Larsen; P Roepstorff
Journal:  Fresenius J Anal Chem       Date:  2000 Mar-Apr

6.  Improved matrix-assisted laser desorption/ionization mass spectrometric analysis of tryptic hydrolysates of proteins following guanidination of lysine-containing peptides.

Authors:  F L Brancia; S G Oliver; S J Gaskell
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

Review 7.  Analysis of phosphorylated proteins and peptides by mass spectrometry.

Authors:  D T McLachlin; B T Chait
Journal:  Curr Opin Chem Biol       Date:  2001-10       Impact factor: 8.822

Review 8.  Tissue transglutaminase: a possible role in neurodegenerative diseases.

Authors:  M Lesort; J Tucholski; M L Miller; G V Johnson
Journal:  Prog Neurobiol       Date:  2000-08       Impact factor: 11.685

9.  Increased sensitivity of tryptic peptide detection by MALDI-TOF mass spectrometry is achieved by conversion of lysine to homoarginine.

Authors:  J E Hale; J P Butler; M D Knierman; G W Becker
Journal:  Anal Biochem       Date:  2000-12-01       Impact factor: 3.365

10.  A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking.

Authors:  P H Jensen; E Schüler; G Woodrow; M Richardson; N Goss; P Højrup; T E Petersen; L K Rasmussen
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

View more
  1 in total

1.  Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease.

Authors:  Adrien W Schmid; Diego Chiappe; Vérène Pignat; Valerie Grimminger; Ivan Hang; Marc Moniatte; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.